Trial intelligence / Profile preview

Teriparatide for Idiopathic Osteoporosis in Premenopausal Women

NCT00697463Phase 3Completed

Sponsor
Columbia University
Start
Aug 2008
Primary completion
Jan 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of teriparatide in idiopathic osteoporosis (IO), sponsored by Columbia University. Started Aug 2008; status: completed.

02

Drugs

teriparatide
03

Conditions

idiopathic osteoporosis (IO)

Beyond the preview

Go deeper on NCT00697463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00697463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call